Amgen says Lumakras plus immunotherapy for lung cancer needs further study
A small study of Amgen Inc's Lumakras drug combined with immunotherapy found it helped 29% of advanced lung cancer patients, ...
A small study of Amgen Inc's Lumakras drug combined with immunotherapy found it helped 29% of advanced lung cancer patients, ...
The Phase two of a multi-million rand programme aimed at strengthening the fight against lung cancer has been launched at ...
Cancer patients have been urged to use the negative thoughts to strengthen their cancer recovery journey. That's the message from ...
South African electrician Phiwankosi Mkhize was diagnosed with lung cancer in May last year and told by the hospital to ...